I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Safety and efficacy of lenvatinib combined with camrelizuma..:
Bo Sun
;
Lijie Zhang
;
Tao Sun
...
https://www.frontiersin.org/articles/10.3389/fonc.2022.982948/full. , 2022
Link:
https://doi.org/10.3389/fonc.2022.982948
RT Journal T1
Safety and efficacy of lenvatinib combined with camrelizumab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A two-center retrospective study
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:eaa231a3ee2748028e422cf67cdc85d9&Exemplar=1&LAN=DE A1 Bo Sun A1 Lijie Zhang A1 Tao Sun A1 Yanqiao Ren A1 Yanyan Cao A1 Weihua Zhang A1 Licheng Zhu A1 Yusheng Guo A1 Yuxi Gui A1 Fengyong Liu A1 Lei Chen A1 Fu Xiong A1 Chuansheng Zheng PB Frontiers Media S.A. YR 2022 K1 lenvatinib K1 transcatheter arterial chemoembolization K1 camrelizumab K1 hepatocellular carcinoma K1 efficacy K1 safety K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2022.982948/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2022.982948 DO https://doi.org/10.3389/fonc.2022.982948 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)